 HLA-DR Antigens
"HLA-DR Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subclass of HLA-D antigens that consist of alpha and beta chains. The inheritance of HLA-DR antigens differs from that of the HLA-DQ ANTIGENS and HLA-DP ANTIGENS.
| Descriptor ID |
D006684
|
| MeSH Number(s) |
D12.776.395.550.509.400.440 D12.776.543.550.423.400.440 D23.050.301.500.400.400.440 D23.050.301.500.450.400.440 D23.050.705.552.410.400.440 D23.050.705.552.450.400.440
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "HLA-DR Antigens".
Below are MeSH descriptors whose meaning is more specific than "HLA-DR Antigens".
This graph shows the total number of publications written about "HLA-DR Antigens" by people in UAMS Profiles by year, and whether "HLA-DR Antigens" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2022 | 1 | 0 | 1 | | 2016 | 0 | 1 | 1 | | 2006 | 1 | 0 | 1 | | 2005 | 1 | 1 | 2 | | 2001 | 1 | 0 | 1 | | 1997 | 1 | 1 | 2 | | 1994 | 1 | 0 | 1 | | 1993 | 0 | 1 | 1 | | 1991 | 0 | 2 | 2 | | 1990 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "HLA-DR Antigens" by people in Profiles over the past ten years.
-
Jevremovic D, Nanaa A, Geyer SM, Timm M, Azouz H, Hengel C, Reberg A, He R, Viswanatha D, Salama ME, Shi M, Olteanu H, Horna P, Otteson G, Greipp PT, Xie Z, Alkhateeb HB, Hogan W, Litzow M, Patnaik MM, Shah M, Al-Kali A, Nguyen PL. Abnormal CD13/HLA-DR Expression Pattern on Myeloblasts Predicts Development of Myeloid Neoplasia in Patients With Clonal Cytopenia of Undetermined Significance. Am J Clin Pathol. 2022 10 06; 158(4):530-536.
-
Puvvada SD, Li H, Rimsza LM, Bernstein SH, Fisher RI, LeBlanc M, Schmelz M, Glinsmann-Gibson B, Miller TP, Maddox AM, Friedberg JW, Smith SM, Persky DO. A phase II study of belinostat (PXD101) in relapsed and refractory aggressive B-cell lymphomas: SWOG S0520. Leuk Lymphoma. 2016 10; 57(10):2359-69.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|